Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5,434,244
-
Total 13F shares
-
6,538,895
-
Share change
-
-2,365,050
-
Total reported value
-
$31,908,000
-
Put/Call ratio
-
175%
-
Price per share
-
$4.88
-
Number of holders
-
48
-
Value change
-
-$11,846,977
-
Number of buys
-
17
-
Number of sells
-
45
Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q2 2021
As of 30 Jun 2021 Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,538,895 shares of stock of the company.
Largest 10 holders included Versant Venture Management, LLC, MORGAN STANLEY, VANGUARD GROUP INC, Redmile Group, LLC, SG Americas Securities, LLC, BlackRock Inc., KENNEDY CAPITAL MANAGEMENT, INC., JACOBS LEVY EQUITY MANAGEMENT, INC, VOLORIDGE INVESTMENT MANAGEMENT, LLC, and PDT Partners, LLC.
This table shows 48 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.